Financhill
Back

DBV Technologies SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
36

DBVT
DBV Technologies SA

Last Price:
0.62
Seasonality Move:
3.6%
Sell
15

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.77
Seasonality Move:
35.83%
Sell
36
DBV Technologies SA (DBVT) is a Sell

Is DBV Technologies SA a Buy, Sell or Hold?

  • The current DBV Technologies SA [DBVT] share price is $0.65. The Score for DBVT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • DBVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.79. The Score for ADAP is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DBVT Stock Price Chart

What is DBV Technologies SA's stock price today?

  • The DBV Technologies SA share price today is $0.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBVT is experiencing slight selling pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.

DBVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 37.36 Sell
Chaikin Money Flow: -21689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.67 - 0.79) Sell
Bollinger Bands (100): (0.71 - 0.91) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 44.49 Sell
Chaikin Money Flow: 908 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.75 - 0.87) Sell
Bollinger Bands (100): (0.85 - 1.21) Sell

DBVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.73 Sell
20-day SMA: 0.74 Sell
50-day SMA: 0.74 Sell
200-day SMA: 1.13 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.73 Sell
50-day EMA: 0.76 Sell
200-day EMA: 1.16 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.81 Sell
20-day SMA: 0.79 Buy
50-day SMA: 0.91 Sell
200-day SMA: 1.13 Sell
8-day EMA: 0.8 Sell
20-day EMA: 0.81 Sell
50-day EMA: 0.89 Sell
200-day EMA: 1.02 Sell

DBV Technologies SA Earnings Growth & DBVT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.19 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.

DBV Technologies SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):